Vaccines have long been seen as a potentially attractive option for treating cancer. Now a group targeting a peptide that plays a key role in CML think they may be onto a winner.
Cancer vaccine for CML shows promise
Related Articles
Cutting Edge
We told you so: How the persistence of
Patient Voice
Shall we try for a baby?
Editorial
Leave a Reply